Detalhe da pesquisa
1.
The effect of renal denervation on arterial stiffness, central blood pressure and heart rate variability in treatment resistant essential hypertension: a substudy of a randomized sham-controlled double-blinded trial (the ReSET trial).
Blood Press
; 26(6): 366-380, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28830251
2.
Coronary plaque quantification and fractional flow reserve by coronary computed tomography angiography identify ischaemia-causing lesions.
Eur Heart J
; 37(15): 1220-7, 2016 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26763790
3.
Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial.
Lancet
; 385(9977): 1527-35, 2015 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25601789
4.
Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial.
Lancet
; 383(9934): 2047-2056, 2014 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24631162
5.
A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial).
Catheter Cardiovasc Interv
; 86(7): 1161-7, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25640050
6.
Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial.
Lancet
; 381(9867): 661-9, 2013 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23374649
7.
Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
Catheter Cardiovasc Interv
; 83(6): 864-72, 2014 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23996918
8.
Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: from Western Denmark Heart Registry.
Catheter Cardiovasc Interv
; 83(7): 1035-42, 2014 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24311384
9.
Clopidogrel discontinuation within the first year after coronary drug-eluting stent implantation: an observational study.
BMC Cardiovasc Disord
; 14: 100, 2014 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25125079
10.
Pre-hospital evaluation of electrocardiographic grade 3 ischemia predicts infarct progression and final infarct size in ST elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
J Electrocardiol
; 47(4): 556-65, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24878030
11.
Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV).
Circulation
; 125(10): 1246-55, 2012 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-22308301
12.
Consideration of QRS complex in addition to ST segment abnormalities in the estimation of the 'risk region' during acute inferior myocardial infarction.
J Electrocardiol
; 46(3): 215-20, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23561836
13.
Zotarolimus-eluting vs. sirolimus-eluting coronary stents in patients with and without acute coronary syndromes: a SORT OUT III substudy.
Eur J Clin Invest
; 42(10): 1047-54, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22624990
14.
Use of clopidogrel and calcium channel blockers and risk of major adverse cardiovascular events.
Eur J Clin Invest
; 42(3): 266-74, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21834799
15.
Concomitant use of clopidogrel and statins and risk of major adverse cardiovascular events following coronary stent implantation.
Br J Clin Pharmacol
; 74(1): 161-70, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22243420
16.
Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy).
BMC Cardiovasc Disord
; 12: 18, 2012 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-22429474
17.
Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry.
BMC Cardiovasc Disord
; 12: 84, 2012 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23031197
18.
Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial.
Lancet
; 375(9720): 1090-9, 2010 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-20231034
19.
Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial.
Lancet
; 375(9716): 727-34, 2010 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-20189026
20.
Consideration of QRS complex in addition to ST-segment abnormalities in the estimated "risk region" during acute anterior myocardial infarction.
J Electrocardiol
; 44(3): 370-6, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21511066